Sonata Capital Group’s GSK GSK Stock Holding History

Sonata Capital Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,404	Closed	-$232K	–	99
2017 Q1	$232K	Hold	4,404	–	–	0.17%	94
2016 Q4	$212K	Sell	4,404 -540	-11%	-$26.7K	0.17%	96
2016 Q3	$267K	Hold	4,944	–	–	0.22%	88
2016 Q2	$268K	Hold	4,944	–	–	0.23%	86
2016 Q1	$251K	Sell	4,944 -240	-5%	-$12K	0.22%	87
2015 Q4	$261K	Hold	5,184	–	–	0.23%	84
2015 Q3	$249K	Hold	5,184	–	–	0.23%	84
2015 Q2	$270K	Buy	5,184 +264	+5%	+$14.9K	0.23%	83
2015 Q1	$284K	Hold	4,920	–	–	0.25%	79
2014 Q4	$263K	Buy	+4,920	New	+$275K	0.24%	82

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sonata Capital Group's GSK Position: Q2 2017 in Review

Sonata Capital Group sold out of GSK (GSK) in Q2 2017, closing a stake of 4,404 shares — an estimated $232K sold.

Sonata Capital Group first reported a position in GSK in Q4 2014 and held it in 10 quarters. The position peaked at $284K in Q1 2015. 780 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Sonata Capital Group reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
Sonata Capital Group sold 4,404 GSK shares in Q2 2017, an estimated $232K.
Sonata Capital Group first reported a position in GSK in Q4 2014 and held it in 10 quarters.
Sonata Capital Group's GSK position peaked at $284K in Q1 2015.
780 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Sonata Capital Group's 13F filing for Q2 2017, filed 1 Aug 2017.